NCT07007260View on ClinicalTrials.gov

Effect of Niacinamide Supplementation in Glaucoma

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Primary Open-Angle Glaucoma (POAG)
Interventions
DIETARY_SUPPLEMENT

niacinamide supplementation

Patients will take niacinamide supplementation (500mg) every day for 1 year

Trial Locations (1)

200349

University of Medicine and Pharmacy of Craiova, Craiova

All Listed Sponsors
lead

University of Medicine and Pharmacy Craiova

OTHER

NCT07007260 - Effect of Niacinamide Supplementation in Glaucoma | Biotech Hunter | Biotech Hunter